Icatibant is a 10 amino acid peptidomimetic of bradykinin and a selective antagonist to the bradykinin B2 receptor. Icabinant has been used for the treatment of attacks in patients with hereditary angioedema. Recent evidence has shown a link between dysregulated bradykinin‐mediated inflammation and acute respiratory distress syndrome (ARDS), a common complication in COVID-19 patients. Icatibant was proposed to inhibit excessive activation of the bradykinin B2 receptor during the SARS-CoV-2 infection, reducing the risk of ARDS.
This report contains market size and forecasts of Icatibatide Acetate in global, including the following market information:
Global Icatibatide Acetate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Icatibatide Acetate Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Icatibatide Acetate companies in 2021 (%)
The global Icatibatide Acetate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Icatibatide Acetate include Bio-Techne, Santa Cruz Biotechnology, Biosynth Carbosynth, BOC Sciences, Bachem, MuseChem, LGC, Clearsynth and Adooq Bioscience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Icatibatide Acetate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Icatibatide Acetate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Icatibatide Acetate Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Icatibatide Acetate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Icatibatide Acetate Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Icatibatide Acetate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Icatibatide Acetate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Icatibatide Acetate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Icatibatide Acetate revenues share in global market, 2021 (%)
Key companies Icatibatide Acetate sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Icatibatide Acetate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Techne
Santa Cruz Biotechnology
Biosynth Carbosynth
BOC Sciences
Bachem
MuseChem
LGC
Clearsynth
Adooq Bioscience
APExBIO Technology
AA Blocks
CSNpharm